Immunic focusing on business development during Q4

Immunic Inc President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive London after the Munich-based biotech company released a third-quarter update.Dr Vitt starts by describing the...

Related Keywords

Munich ,Bayern ,Germany ,United States ,London ,City Of ,United Kingdom ,Thomas Warner ,Daniel Vitt ,Us Patent Office ,Immunic Inc ,Sinc President ,Proactive London ,Progressive Multiple ,